KALA BIO, Inc.’s EPS Growth at a glance
KALA BIO, Inc. reports eps growth of 59.8% for Dec 2024. The prior period recorded 41.1% (Dec 2023). Year over year the metric moved +18.6 pts (+45.3%). The rolling three-period average stands at 58%. Data last refreshed Dec 4, 2025, 7:24 PM.
Latest reading
59.8% · Dec 2024
YoY movement
+18.6 pts (+45.3%)
Rolling average
58%
Current EPS Growth
59.8%
+18.6 pts
+45.3%
Rolling average
58%
Latest Value
59.8%
Dec 2024
YoY Change
+18.6 pts
Absolute
YoY Change %
+45.3%
Rate of change
3-Period Avg
58%
Smoothed
Narrative signal
KALA BIO, Inc.’s eps growth stands at 59.8% for Dec 2024. Year-over-year, the metric shifted by +18.6 pts, translating into a +45.3% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How eps growth shapes KALA BIO, Inc.'s story
As of Dec 2024, KALA BIO, Inc. reports eps growth of 59.8%. Review EPS trajectory, compounding pace, and earnings momentum supported by trailing annual filings.
Understanding EPS momentum
Sustained positive EPS growth underpins long-term shareholder returns. Volatility often reflects cyclical businesses or share-count changes.
Check the drivers behind EPS
Analyze revenue growth, margin expansion, and buybacks to see which levers are powering EPS gains.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
KALA BIO, Inc. (KALA) FAQs
Answers tailored to KALA BIO, Inc.’s eps growth profile using the latest Financial Modeling Prep data.
What is KALA BIO, Inc.'s current eps growth?
As of Dec 2024, KALA BIO, Inc. reports eps growth of 59.8%. This reading reflects the latest filings and price data for KALA.
How is KALA BIO, Inc.'s eps growth trending year over year?
Year-over-year, the figure shifts by +18.6 pts (+45.3%). Pair this context with revenue growth and free cash flow signals to gauge momentum for KALA.
Why does eps growth matter for KALA BIO, Inc.?
Earnings-per-share growth reveals how quickly per-share net income is expanding or contracting versus the prior year. For KALA BIO, Inc., operating within Healthcare — Biotechnology, tracking this metric helps benchmark management's execution against close competitors.
Is KALA BIO, Inc.'s eps growth above its recent average?
KALA BIO, Inc.'s rolling three-period average sits at 58%. Comparing the latest reading of 59.8% to that baseline highlights whether momentum is building or fading for KALA.
How frequently is KALA BIO, Inc.'s eps growth refreshed?
Data for KALA was last refreshed on Dec 4, 2025, 7:24 PM and updates automatically every 24 hours, keeping your valuation inputs current.